| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-10 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-07 |
| mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
| mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-06 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |